Loading
Matterworks
Matterworks, Inc. is a biotechnology and artificial intelligence company based in Somerville, Massachusetts. Founded in 2019, the company focuses on harnessing biological data through AI-driven platforms, particularly in the field of metabolomics, which studies small molecules within cells. Matterworks aims to democratize access to metabolomics and enhance its application in life sciences. The company offers a range of services that integrate AI into biological research, biomanufacturing, and drug development. These include predictive biology solutions, automated metabolomics, data interpretation and analysis, secure data infrastructure, and support for therapeutic and bioprocess development. Matterworks has developed two key products: the Large Spectral Model (LSM), which interprets biochemical data using self-supervised machine intelligence, and the Pyxis™ platform, which automates the identification and quantification of analytes from mass spectrometry data. Matterworks serves professionals in biotechnology research, life sciences, HealthTech, and pharmaceuticals, providing advanced computational solutions to accelerate scientific progress and the development of new therapies.
Funding
Every round, secondary, debt facility or acquisition involving Matterworks that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—